Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.3 Market by Application
1.3.1 Global Melanoma Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Drugs Market Perspective (2018-2029)
2.2 Melanoma Drugs Growth Trends by Region
2.2.1 Global Melanoma Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Melanoma Drugs Historic Market Size by Region (2018-2024)
2.2.3 Melanoma Drugs Forecasted Market Size by Region (2024-2029)
2.3 Melanoma Drugs Market Dynamics
2.3.1 Melanoma Drugs Industry Trends
2.3.2 Melanoma Drugs Market Drivers
2.3.3 Melanoma Drugs Market Challenges
2.3.4 Melanoma Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Drugs Players by Revenue
3.1.1 Global Top Melanoma Drugs Players by Revenue (2018-2024)
3.1.2 Global Melanoma Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Melanoma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Melanoma Drugs Revenue
3.4 Global Melanoma Drugs Market Concentration Ratio
3.4.1 Global Melanoma Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Drugs Revenue in 2022
3.5 Melanoma Drugs Key Players Head office and Area Served
3.6 Key Players Melanoma Drugs Product Solution and Service
3.7 Date of Enter into Melanoma Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Drugs Breakdown Data by Type
4.1 Global Melanoma Drugs Historic Market Size by Type (2018-2024)
4.2 Global Melanoma Drugs Forecasted Market Size by Type (2024-2029)
5 Melanoma Drugs Breakdown Data by Application
5.1 Global Melanoma Drugs Historic Market Size by Application (2018-2024)
5.2 Global Melanoma Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Melanoma Drugs Market Size (2018-2029)
6.2 North America Melanoma Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Melanoma Drugs Market Size by Country (2018-2024)
6.4 North America Melanoma Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Melanoma Drugs Market Size (2018-2029)
7.2 Europe Melanoma Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Melanoma Drugs Market Size by Country (2018-2024)
7.4 Europe Melanoma Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Drugs Market Size (2018-2029)
8.2 Asia-Pacific Melanoma Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Melanoma Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Melanoma Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Melanoma Drugs Market Size (2018-2029)
9.2 Latin America Melanoma Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Melanoma Drugs Market Size by Country (2018-2024)
9.4 Latin America Melanoma Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Drugs Market Size (2018-2029)
10.2 Middle East & Africa Melanoma Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Melanoma Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Melanoma Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Melanoma Drugs Introduction
11.1.4 Amgen Revenue in Melanoma Drugs Business (2018-2024)
11.1.5 Amgen Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Melanoma Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2018-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Melanoma Drugs Introduction
11.3.4 Roche Revenue in Melanoma Drugs Business (2018-2024)
11.3.5 Roche Recent Development
11.4 Genentech
11.4.1 Genentech Company Detail
11.4.2 Genentech Business Overview
11.4.3 Genentech Melanoma Drugs Introduction
11.4.4 Genentech Revenue in Melanoma Drugs Business (2018-2024)
11.4.5 Genentech Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Melanoma Drugs Introduction
11.5.4 Janssen Biotech Revenue in Melanoma Drugs Business (2018-2024)
11.5.5 Janssen Biotech Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Melanoma Drugs Introduction
11.6.4 Novartis Revenue in Melanoma Drugs Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Melanoma Drugs Introduction
11.7.4 Pfizer Revenue in Melanoma Drugs Business (2018-2024)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Melanoma Drugs Introduction
11.8.4 Sanofi Revenue in Melanoma Drugs Business (2018-2024)
11.8.5 Sanofi Recent Development
11.9 Takeda Pharma
11.9.1 Takeda Pharma Company Detail
11.9.2 Takeda Pharma Business Overview
11.9.3 Takeda Pharma Melanoma Drugs Introduction
11.9.4 Takeda Pharma Revenue in Melanoma Drugs Business (2018-2024)
11.9.5 Takeda Pharma Recent Development
11.10 Teva Pharma
11.10.1 Teva Pharma Company Detail
11.10.2 Teva Pharma Business Overview
11.10.3 Teva Pharma Melanoma Drugs Introduction
11.10.4 Teva Pharma Revenue in Melanoma Drugs Business (2018-2024)
11.10.5 Teva Pharma Recent Development
11.11 Merck Group
11.11.1 Merck Group Company Detail
11.11.2 Merck Group Business Overview
11.11.3 Merck Group Melanoma Drugs Introduction
11.11.4 Merck Group Revenue in Melanoma Drugs Business (2018-2024)
11.11.5 Merck Group Recent Development
11.12 Shanghai Junshi Biosciences Co.,Ltd
11.12.1 Shanghai Junshi Biosciences Co.,Ltd Company Detail
11.12.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview
11.12.3 Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Introduction
11.12.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Melanoma Drugs Business (2018-2024)
11.12.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development
11.13 Innovent Biologics
11.13.1 Innovent Biologics Company Detail
11.13.2 Innovent Biologics Business Overview
11.13.3 Innovent Biologics Melanoma Drugs Introduction
11.13.4 Innovent Biologics Revenue in Melanoma Drugs Business (2018-2024)
11.13.5 Innovent Biologics Recent Development
11.14 Jiangsu Hengrui Medicine Co.,Ltd.
11.14.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
11.14.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.14.3 Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Introduction
11.14.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Melanoma Drugs Business (2018-2024)
11.14.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
11.15 BeiGene, Ltd.
11.15.1 BeiGene, Ltd. Company Detail
11.15.2 BeiGene, Ltd. Business Overview
11.15.3 BeiGene, Ltd. Melanoma Drugs Introduction
11.15.4 BeiGene, Ltd. Revenue in Melanoma Drugs Business (2018-2024)
11.15.5 BeiGene, Ltd. Recent Development
11.16 Grand Pharmaceutical (China) Co., Ltd
11.16.1 Grand Pharmaceutical (China) Co., Ltd Company Detail
11.16.2 Grand Pharmaceutical (China) Co., Ltd Business Overview
11.16.3 Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Introduction
11.16.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Melanoma Drugs Business (2018-2024)
11.16.5 Grand Pharmaceutical (China) Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Melanoma Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Global Melanoma Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Melanoma Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Melanoma Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Melanoma Drugs Market Share by Region (2018-2024)
Table 9. Global Melanoma Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Melanoma Drugs Market Share by Region (2024-2029)
Table 11. Melanoma Drugs Market Trends
Table 12. Melanoma Drugs Market Drivers
Table 13. Melanoma Drugs Market Challenges
Table 14. Melanoma Drugs Market Restraints
Table 15. Global Melanoma Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Melanoma Drugs Market Share by Players (2018-2024)
Table 17. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Drugs as of 2022)
Table 18. Ranking of Global Top Melanoma Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Melanoma Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Melanoma Drugs Product Solution and Service
Table 22. Date of Enter into Melanoma Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanoma Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Melanoma Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Melanoma Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Melanoma Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Melanoma Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Melanoma Drugs Revenue Market Share by Application (2018-2024)
Table 30. Global Melanoma Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Melanoma Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Melanoma Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Melanoma Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Melanoma Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Melanoma Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Melanoma Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Melanoma Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Melanoma Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Melanoma Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Melanoma Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Melanoma Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Melanoma Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Melanoma Drugs Product
Table 50. Amgen Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Bristol-Myers Squibb Company Detail
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb Melanoma Drugs Product
Table 55. Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 56. Bristol-Myers Squibb Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche Melanoma Drugs Product
Table 60. Roche Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 61. Roche Recent Development
Table 62. Genentech Company Detail
Table 63. Genentech Business Overview
Table 64. Genentech Melanoma Drugs Product
Table 65. Genentech Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 66. Genentech Recent Development
Table 67. Janssen Biotech Company Detail
Table 68. Janssen Biotech Business Overview
Table 69. Janssen Biotech Melanoma Drugs Product
Table 70. Janssen Biotech Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 71. Janssen Biotech Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Melanoma Drugs Product
Table 75. Novartis Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Melanoma Drugs Product
Table 80. Pfizer Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Sanofi Company Detail
Table 83. Sanofi Business Overview
Table 84. Sanofi Melanoma Drugs Product
Table 85. Sanofi Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Takeda Pharma Company Detail
Table 88. Takeda Pharma Business Overview
Table 89. Takeda Pharma Melanoma Drugs Product
Table 90. Takeda Pharma Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 91. Takeda Pharma Recent Development
Table 92. Teva Pharma Company Detail
Table 93. Teva Pharma Business Overview
Table 94. Teva Pharma Melanoma Drugs Product
Table 95. Teva Pharma Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 96. Teva Pharma Recent Development
Table 97. Merck Group Company Detail
Table 98. Merck Group Business Overview
Table 99. Merck Group Melanoma Drugs Product
Table 100. Merck Group Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 101. Merck Group Recent Development
Table 102. Shanghai Junshi Biosciences Co.,Ltd Company Detail
Table 103. Shanghai Junshi Biosciences Co.,Ltd Business Overview
Table 104. Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Product
Table 105. Shanghai Junshi Biosciences Co.,Ltd Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 106. Shanghai Junshi Biosciences Co.,Ltd Recent Development
Table 107. Innovent Biologics Company Detail
Table 108. Innovent Biologics Business Overview
Table 109. Innovent Biologics Melanoma Drugs Product
Table 110. Innovent Biologics Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 111. Innovent Biologics Recent Development
Table 112. Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
Table 113. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 114. Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Product
Table 115. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 116. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
Table 117. BeiGene, Ltd. Company Detail
Table 118. BeiGene, Ltd. Business Overview
Table 119. BeiGene, Ltd. Melanoma Drugs Product
Table 120. BeiGene, Ltd. Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 121. BeiGene, Ltd. Recent Development
Table 122. Grand Pharmaceutical (China) Co., Ltd Company Detail
Table 123. Grand Pharmaceutical (China) Co., Ltd Business Overview
Table 124. Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Product
Table 125. Grand Pharmaceutical (China) Co., Ltd Revenue in Melanoma Drugs Business (2018-2024) & (US$ Million)
Table 126. Grand Pharmaceutical (China) Co., Ltd Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Drugs Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Melanoma Drugs Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Features
Figure 4. Immunotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Global Melanoma Drugs Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Melanoma Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Melanoma Drugs Report Years Considered
Figure 12. Global Melanoma Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Melanoma Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Melanoma Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Melanoma Drugs Market Share by Players in 2022
Figure 16. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Melanoma Drugs Revenue in 2022
Figure 18. North America Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Melanoma Drugs Market Share by Country (2018-2029)
Figure 20. United States Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Melanoma Drugs Market Share by Country (2018-2029)
Figure 24. Germany Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Melanoma Drugs Market Share by Region (2018-2029)
Figure 32. China Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Melanoma Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Melanoma Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Melanoma Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Amgen Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 48. Roche Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 49. Genentech Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 50. Janssen Biotech Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 51. Novartis Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 52. Pfizer Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 53. Sanofi Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 54. Takeda Pharma Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 55. Teva Pharma Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 56. Merck Group Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 57. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 58. Innovent Biologics Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 59. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 60. BeiGene, Ltd. Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 61. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Melanoma Drugs Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed